Table 2.
Post transplant outcomes:
| Median follow up, days (range) | 364 (7-2,815) | |
| Neutrophil engraftment (days)
Median (range) |
15 (11-16) | |
| Platelet engraftment (days)
Median (range) |
16.5 (13-42) | |
| Graft failure | None | |
| Acute GvHD (Grades II-IV) | 4 (27%) | |
| Chronic GvHD (limited) | 4 (27%) | |
| CMV reactivation | 1 (6.6%) | |
| Culture positive sepsis | 6 | |
| Expired | Sepsis related | 5 |
| GvHD related | 1 | |
| Total | 6 (40%) | |
| TRM/NRM | 6/15 (40%) | |
| DFS | 9/15 (60%) | |
| OS | 9/15 (60%) | |
TRM/NRM, transplant-related mortality/non-relapse mortality; DFS, disease free survival; OS, overall survival